The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan

OBJECTIVES/HYPOTHESIS: Dupilumab, which blocks the shared receptor component for interleukin‐4 and interleukin‐13, reduced polyp size, sinus opacification, and symptom severity, and was well tolerated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the SINUS‐52 study (NCT028984...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Laryngoscope
Glavni autori: Fujieda, Shigeharu, Matsune, Shoji, Takeno, Sachio, Asako, Mikiya, Takeuchi, Makiko, Fujita, Hiroyuki, Takahashi, Yoshinori, Amin, Nikhil, Deniz, Yamo, Rowe, Paul, Mannent, Leda
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Allergy, Rhinology, and Immunology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247406/
https://ncbi.nlm.nih.gov/pubmed/33226139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.29230
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items